Halbert Hargrove Global Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,375
Closed -$201K 75
2017
Q3
$201K Buy
+1,375
New +$187K 0.06% 65
2017
Q2
Sell
-2,032
Closed -$253K 80
2017
Q1
$253K Buy
2,032
+173
+9% +$20.7K 0.06% 66
2016
Q4
$215K Buy
+1,859
New +$207K 0.06% 65
2016
Q3
Sell
-2,263
Closed -$223K 78
2016
Q2
$223K Buy
2,263
+187
+9% +$19.3K 0.06% 66
2016
Q1
$208K Sell
2,076
-531
-20% -$54.7K 0.07% 75
2015
Q4
$312K Sell
2,607
-149
-5% -$17.2K 0.13% 61
2015
Q3
$298K Sell
2,756
-3,282
-54% -$407K 0.15% 59
2015
Q2
$699K Sell
6,038
-2,034
-25% -$233K 0.17% 47
2015
Q1
$931K Buy
8,072
+2,858
+55% +$342K 0.3% 33
2014
Q4
$583K Sell
5,214
-93
-2% -$9.81K 0.29% 33
2014
Q3
$503K Sell
5,307
-6,133
-54% -$553K 0.14% 56
2014
Q2
$982K Buy
11,440
+42
+0.4% +$3.19K 0.3% 16
2014
Q1
$796K Sell
11,398
-738
-6% -$58.4K 0.24% 20
2013
Q4
$1.02M Sell
12,136
-2,542
-17% -$201K 0.32% 15
2013
Q3
$1.13M Sell
14,678
-1,988
-12% -$139K 0.37% 12
2013
Q2
$975K Buy
+16,666
New +$1M 0.36% 13

Other funds holding CELG

Halbert Hargrove Global Advisors's CELG Position: Q4 2017 in Review

Halbert Hargrove Global Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,375 shares — an estimated $201K sold.

Halbert Hargrove Global Advisors first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $1.13M in Q3 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Halbert Hargrove Global Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 1,375 Celgene Corp shares in Q4 2017, an estimated $201K.
  • Halbert Hargrove Global Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
  • Halbert Hargrove Global Advisors's Celgene Corp position peaked at $1.13M in Q3 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Halbert Hargrove Global Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.